FDA poised to outlaw breast reconstruction for breast cancer survivors using their own fat tissue

The U.S. Food and Drug Administration held public hearings for two days this week to allow for public commenting on proposed guidance relating to the regulation of human cells, tissues or tissue-based products. In its current form, this guidance will classify a woman’s own fat tissue as a drug when used in breast reconstruction procedures. [...]

2016-09-15T16:40:41+00:00September 15th, 2016|Bone Marrow Stem Cells, Breast Cancer, Cancer, FDA, News|